Coronavirus

Free access to BioWorld coronavirus articles

April 8, 2020

The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are constantly updated:

Vaccines and therapeutics in development

Diagnostics on the market and in development

Clinical trials of biopharma and med-tech products affected by COVID-19

The next pandemic: Diagnostics

Excess testing capacity essential for next pandemic, but cost question not yet answered

April 8, 2020

By Mark McCarty

No Comments

There will be lessons learned aplenty when the COVID-19 pandemic finally breaks, including how serological and molecular testing can be used to maximum effect to corral a future pandemic. Carmen Wiley, president of the American Association of Clinical Chemistry, told BioWorld that the existing instrument types are up to the job, but that surge capacity is needed, and that it is not clear how the cost of that capacity will be handled.

Tyto Care sees $50M in new funding round for telehealth system

April 8, 2020

By Anette Breindl

No Comments

Tyto Care Ltd. nabbed $50 million in an oversubscribed round of funding the company will use to expand commercialization of its integrated telehealth platform and remote device with examination tools, which has seen a surge in demand with COVID-19. The new cash nearly doubles the New York-based company's total funding, bringing it to $105 million. Insight Partners, Olive Tree Ventures, and Qualcomm Ventures LLC led the latest round.

Genmark boosts full-year guidance as Eplex placements rise

April 8, 2020

By Liz Hollis

No Comments

Amid the COVID-19 pandemic, Genmark Diagnostics Inc., of Carlsbad, Calif., has offered a preliminary look at its first-quarter results. And it is forecasting hopeful news, increasing its full-year guidance to a range of $112 million to $122 million. That's up from a previous prediction of $100 million to $110 million.

India lifts export restrictions even as domestic demand increases

April 8, 2020

By David Ho

No Comments

HONG KONG – India has lifted some restrictions on the export of its medical supplies in light of the global battle against the COVID-19 novel coronavirus. Last month, Indian authorities started restricting the export of certain active pharmaceutical ingredients (APIs) and the formulations based on some specific APIs.

Bad info, delusions about testing fuel COVID-19 viral spiral

April 8, 2020

By Randy Osborne

No Comments

Evercore ISI assembled a dozen internal specialists for a webinar to talk about COVID-19 from a variety of perspectives, with opinions aplenty on transmission route, up-and-coming treatment prospects, and problems in how testing procedures are understood – or not.

Regulatory front for April 8, 2020

April 8, 2020

No Comments

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: General Motors, Inbios International, Philips, Ventec Life Systems.

Other news to note for April 8, 2020

April 8, 2020

No Comments

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allen Technologies, Alphatec Holdings, Auburn University, Avacta Group, Biobot Analytics, Biodesix, Chembio Diagnostics, Cryo Innovations, Cytiva, Genomoncology, Hai Kang, HPC-AI, Integra Lifesciences, Intuitive, JMA, Labcorp, Myomo, Myriad, Nanomix, National Supercomputing Centre, Novacyt Group, Organovo, Pacific Biosciences of California, Pharmacyte, Phunware, Ping An Good Doctor, Predictive Laboratories, Resolution Medical, Roji Health Intelligence, Tarveda Therapeutics, Vitalhub, Wellgistics.

Toward breathing easier

Novavax coronavirus vaccine, Bellerophon COVID-19 therapy near phase I

April 8, 2020

By Michael Fitzhugh

No Comments

Novavax Inc., one of the first biopharma companies to reveal its efforts to develop a SARS-CoV-2 vaccine in January, has identified a prefusion protein for testing in an Australian phase I trial, slated to start in mid-May.

BioWorld MedTech’s Orthopedics Extra for April 8, 2020

April 8, 2020

By Holland Johnson

No Comments

Keeping you up to date on recent developments in orthopedics, including: Excess weight during pre-school linked to higher bone fracture risk; Cells must age for muscles to regenerate in muscle-degenerating diseases; COVID-19 pandemic may exacerbate childhood obesity.

Coronavirus
RSS

Free access to BioWorld coronavirus articles

Excess testing capacity essential for next pandemic, but cost question not yet answered

Tyto Care sees $50M in new funding round for telehealth system

Genmark boosts full-year guidance as Eplex placements rise

India lifts export restrictions even as domestic demand increases

Bad info, delusions about testing fuel COVID-19 viral spiral

Regulatory front for April 8, 2020

Other news to note for April 8, 2020

Novavax coronavirus vaccine, Bellerophon COVID-19 therapy near phase I

BioWorld MedTech’s Orthopedics Extra for April 8, 2020

Popular Stories

South Korea approves first four COVID-19 test kits under urgent-use license

Two South Korean COVID-19 kits look overseas, seek FDA approval

Noninvasive ventilation options explored for COVID-19, as FDA eases with guidance

FDA says yes to NO: Bellerophon Therapeutics wins expanded access approval for inhaled nitric oxide system

Antiviral favipiravir effective against COVID-19, China says

BioWorld Premium

Coronavirus RSS

Popular Stories

BioWorld Premium

Coronavirus
RSS